EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery: S 1789 and HR 2309

Contacted: Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Executive Office of the President (EOP); Federal Trade Commission (FTC); White House Office; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Government Accountability Office (GAO)

Bills named: H.R. 2309 (112th)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1409, HR 1946, HR 1839).

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Government Accountability Office (GAO); Executive Office of the President (EOP); White House Office; Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1409 (112th), H.R. 1839 (112th), H.R. 1946 (112th)

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual National Defense Authorization Act of 2012.

Contacted: Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); White House Office; Federal Trade Commission (FTC); Government Accountability Office (GAO); Labor, Dept of (DOL); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Internal Revenue Service (IRS); Executive Office of the President (EOP); Food & Drug Administration (FDA); White House Office; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); SENATE

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures FDA Safety and Innovation Act: S. 3187, H.R.3988, H.R.4087, H.R.5334, S.2236, S.2289, S.2516: issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: Executive Office of the President (EOP); SENATE; White House Office; Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Government Accountability Office (GAO); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS)

Bills named: S. 2289 (112th), S. 3187 (112th), S. 2516 (112th), H.R. 4087 (112th), H.R. 5334 (112th), S. 2236 (112th), H.R. 3988 (112th)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (HR 2190, HR 2248, S 1206) & MTM expansion (HR 891/S 274). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price (HR 905/S 733). Medicare audit restrictions (HR 4215)

Contacted: Internal Revenue Service (IRS); Food & Drug Administration (FDA); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO)

Bills named: H.R. 905 (112th), H.R. 891 (112th), H.R. 2190 (112th), H.R. 2248 (112th), H.R. 4215 (112th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058). FDA Safety and Innovation Act: S. 3187, H.R.3988, H.R.4087, H.R.5334, S.2236, S.2289, S.2516: issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: Federal Trade Commission (FTC); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Labor, Dept of (DOL); SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA)

Bills named: S. 2289 (112th), S. 27 (112th), H.R. 3988 (112th), S. 3187 (112th), H.R. 979 (112th), H.R. 1971 (112th), H.R. 5334 (112th), H.R. 4087 (112th), S. 2236 (112th), S. 2516 (112th)